Effects_of_Propidium_Monoazide_(PMA)_Treatment_on_Mycobiome_and_Bacteriome_Analysis_of_Cystic_Fibrosis_Airways_during_Exacerbation

Visibility: Public
Publication: Effects_of_Propidium_Monoazide_(PMA)_Treatment_on_Mycobiome_and_Bacteriome_Analysis_of_Cystic_Fibrosis_Airways_during_Exacerbation Link
Journal: PLoS_One
Source: NA
Sample Number: 36

Samples in this project
  

SampleID Type Habitat Year Sequence type MNS1 MAS2
S_ERP016649.ERR1551897 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551899 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551900 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551902 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551905 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551907 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551910 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551912 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551915 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551917 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551920 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551925 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551928 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551930 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551933 Other_humanbodysite Lung NA 16S_V3-V5 - -
S_ERP016649.ERR1551935 Other_humanbodysite Lung NA 16S_V3-V5 - -

1MNS (Microbiome Novelty Score): < 0.12: Non-novel; 0.12-0.2: Novel; > 0.2: Very novel; -: NA for samples before 2010

2MAS (Microbiome Attention Score): < 10: Low-attention; ≥ 10: High-attention; -: NA for samples before 2010